Affiliated Hospital of Yangzhou University

Yangzhou, Jiangsu 225007

0 studies enrolling now · 2 studies all time

What they study most

Acute Non-cardioembolic Ischemic Stroke, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, High-risk Transient Ischemic Attack, Prevention of Ischemic Stroke

Studies at this site

• Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untreated Advanced Gastric and Gastroesophageal Junction Cancer. — Stopped early
• A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke — Completed